Clearmind Medicine (CMND) Net Cash Flow (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Net Cash Flow of $2.8 million for Q2 2026, up 314.71% year-over-year from $677558.3 in Q2 2025, and down 47.3% quarter-over-quarter from $5.3 million in Q1 2026.
Clearmind Medicine (CMND) Net Cash Flow (2022 - 2026) Analysis & Trends
Clearmind Medicine's Net Cash Flow history runs 5 years deep, the most recent figure standing at $2.8 million for Q2 2026.
- In Q2 2026, Net Cash Flow rose 314.71% year-over-year to $2.8 million; the TTM figure through Apr 2026 stood at $7.6 million (up 298.24% YoY), while the FY2025 annual figure was -$2.7 million, down 329.26% from the prior year.
- Net Cash Flow for Q2 2026 stood at $2.8 million, down from $5.3 million in the prior quarter.
- The five-year high for Net Cash Flow was $5.3 million in Q1 2026, with the low at -$2937.9 billion in Q3 2022.
- The 5-year median for Net Cash Flow is -$791161.0 (2025), against an average of -$195.9 billion.
- The sharpest annual moves came in 2024 and 2026: Net Cash Flow sank 168.25% in 2024, then soared 773.98% in 2026.
- Clearmind Medicine's Net Cash Flow stood at -$2937.9 billion in 2022, then soared by 100.0% to $1.6 million in 2023, then tumbled by 168.25% to -$1.1 million in 2024, then jumped by 138.81% to $428581.0 in 2025, then surged by 555.63% to $2.8 million in 2026.
- Business Quant data shows CMND's Net Cash Flow at $2.8 million in Q2 2026, $5.3 million in Q1 2026, and $428581.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | 2.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.81 Mn |
| Apr 30, 2026 | 2.81 Mn |
| Jan 31, 2026 | 5.33 Mn |
| Jan 31, 2026 | 5.33 Mn |
| Oct 31, 2025 | 428,581.00 |
| Oct 31, 2025 | 428,581.00 |
| Jul 31, 2025 | -982,696.00 |
| Jul 31, 2025 | -982,696.00 |
| Apr 30, 2025 | -1.31 Mn |
| Apr 30, 2025 | -1.31 Mn |
| Jan 31, 2025 | -791,161.00 |
| Jan 31, 2025 | -791,161.00 |
| Oct 31, 2024 | -1.10 Mn |
| Oct 31, 2024 | -1.10 Mn |
| Jul 31, 2024 | -623,401.00 |
| Jul 31, 2024 | -623,401.00 |
| Apr 30, 2024 | -1.05 Mn |
| Apr 30, 2024 | -1.05 Mn |
| Jan 31, 2024 | 3.85 Mn |
| Jan 31, 2024 | 3.85 Mn |